Skip navigation

Business Intelligence Breakfast: The CRISPR Clash – An Update on the Ongoing Patent Battles

08:00 - 10:00

Location:
Boult Wade Tennant, CPC4 Capital Park, Cambridge Rd, Fulbourn, Cambridge CB21 5XE
Date:
08 March 2017
 


CRISPR/Cas gene editing technology is transforming biological research.

Since 2012, the number of publications describing CRISPR/Cas gene editing and its applications has increased exponentially. Almost as high profile as the technology itself is the question of which party will secure the dominant patent rights. Inventors from two universities, the University of California, Berkeley and the Broad Institute each claim to have made the key inventions that enable the various practical applications of the technology.

These universities are now embroiled in battles both sides of the pond to attempt to settle this dispute. But this legal uncertainty does not appear to have prevented commercial activity in the area, with each of the three main inventors involved with different CRISPR/Cas start-ups. In this session we will review the current status of the key patent disputes in the US and Europe and comment on the current commercial activity and how it might be affected by the patent position.


Programme

08.00 – Delegates Registration Over Tea and Coffee

08.30 – Update on CRISPR Patent
Matthew Spencer, Partner Biotechnology and Life Science group, Boult Wade Tennant
To view the presentation, please click here.

09.30 – Networking over Tea and Coffee

10.00 - End

Places for this event are limited. If you would like to attend, please contact Aline, aline@onenucleus.com.
Title: Business Intelligence Breakfast: The CRISPR Clash – An Update on the Ongoing Patent Battles
Start: 2017-03-08 08:00:00Z
End: 2017-03-08 10:00:00Z